UnitedHealth Group, Abbott Laboratories, and AbbVie are highlighted as promising medical stocks due to their high recent trading volumes and strong market presence. These companies operate across diverse healthcare segments including insurance, pharmaceuticals, diagnostics, and treatments for various diseases. Their performance is influenced by factors like clinical trials, regulatory approvals, and healthcare policies, making them key players for investors seeking exposure to the medical sector. Monitoring these stocks could offer insights into healthcare industry trends and investment opportunities.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
